Literature DB >> 33237384

Authors' reply to letters to the editor "model-based simulation to support the extended dosing regimens of atezolizumab".

Chen-Hsi Chou1,2, Li-Feng Hsu3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33237384     DOI: 10.1007/s00228-020-03055-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  1 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma.

Authors:  M Stroh; H Winter; M Marchand; L Claret; S Eppler; J Ruppel; O Abidoye; S L Teng; W T Lin; S Dayog; R Bruno; J Jin; S Girish
Journal:  Clin Pharmacol Ther       Date:  2017-06-09       Impact factor: 6.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.